A- and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes

The cell cycle is regulated by cyclin-dependent kinases (cdks), which are activated by binding to cyclin subunits. While cyclins A and B are known to activate distinct cdks, the mechanism by which these complexes recognize and phosphorylate specific substrates remains unclear. Prior research has shown that cyclin-cdk complexes can phosphorylate histone H1 and other cyclin subunits, but differences in substrate specificity have not been fully resolved. This gap motivated investigations into whether the kinase or the cyclin determines substrate recognition. It was already known that cyclin A and B associate with cdk2 and cdc2, but their distinct roles in substrate selection had not been established. No prior work had resolved whether cyclin A or B is responsible for directing phosphorylation of specific proteins like p107. The uncertainty around cyclin-cdk complex specificity in targeting substrates led to this study. This investigation aimed to clarify whether the kinase or cyclin subunit is primarily responsible for substrate selection. The study sought to determine the role of cyclin A and B in modulating the substrate specificity of cyclin-cdk complexes.

This study aimed to determine whether the kinase or cyclin subunit in cyclin-cdk complexes is primarily responsible for substrate specificity. The specific problem addressed was the lack of clarity about which component—cyclin A, cyclin B, or the kinase—determines the ability of the complex to phosphorylate specific proteins like p107. The motivation for this work was to resolve the role of cyclin subunits in directing substrate recognition by cyclin-cdk complexes. The researchers sought to test whether cyclin A and B differ in their ability to target specific substrates. The study focused on the phosphorylation of p107 by cyclin A-cdk and cyclin B-cdk complexes. The goal was to determine whether cyclin A or B is critical for binding to and phosphorylating p107. The researchers also aimed to assess whether the kinase alone could mediate binding to p107. The study sought to clarify whether cyclin A-p33cdk2 is the primary kinase for p107 phosphorylation in vivo.

The researchers used in vitro phosphorylation assays to compare the activity of cyclin A-cdk and cyclin B-cdk complexes on histone H1 and p107. They tested whether the kinase subunit alone could phosphorylate p107 or if the cyclin was required. Binding assays were conducted to determine whether cyclin A-cdk and cyclin B-cdk complexes could associate with p107 under identical conditions. The study employed purified cyclin A, cyclin B, p33cdk2, and p34cdc2 proteins. The researchers assessed phosphorylation of p107 at sites known to be phosphorylated in human cells. They compared the phosphorylation patterns of p107 by cyclin A-p33cdk2 and cyclin B-p34cdc2 complexes. The study also examined whether binding to p107 required both cyclin and kinase subunits. The researchers used biochemical assays to measure substrate phosphorylation and protein-protein interactions.

Cyclin A and B-cdk complexes phosphorylated histone H1 and their cyclin subunits similarly, regardless of the kinase used. However, only cyclin A-cdk complexes phosphorylated p107 in vitro. Binding assays showed that cyclin A-cdk complexes stably bound to p107, while cyclin B-cdk complexes did not. Neither cyclin A nor the kinase alone bound to p107, indicating that both subunits are required for binding. The kinase subunit was necessary but not sufficient for p107 recognition. The cyclin subunit played a critical role in directing the complex to p107. The cyclin A-p33cdk2 complex phosphorylated p107 at most of the sites observed in human cells. These results suggest that cyclin A-p33cdk2 is a major kinase for p107 in vivo. The study demonstrated that cyclin subunits, not kinases, determine substrate specificity in cyclin-cdk complexes.

The authors propose that cyclin subunits, rather than kinase subunits, are primarily responsible for determining substrate specificity in cyclin-cdk complexes. The study shows that cyclin A-cdk complexes, but not cyclin B-cdk complexes, can phosphorylate p107 in vitro. The researchers suggest that binding to p107 requires both cyclin A and a cdk. The kinase subunit is necessary but not sufficient for p107 recognition. The cyclin subunit appears to be the critical determinant of substrate targeting. The study indicates that cyclin A-p33cdk2 is a major kinase for p107 in vivo. The findings suggest that cyclin subunits modulate the substrate specificity of cyclin-cdk complexes. These results support the idea that cyclin subunits play a central role in directing cyclin-cdk activity to specific substrates.